Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.449NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.152NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.146NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.71NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.445NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.75.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.56.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.13.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDLNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.338NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.20.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.80NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.134NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used